Table 1.
Basic information of all study groups.
| Group (n) | PA (14) | MEC (12) | AdCC (15) | NSG (5) | Total (46) |
|---|---|---|---|---|---|
| Age | 39.4 ± 14 | 60.6 ± 12 | 49.7 ± 12 | 49 ± 14 | 49.4 ± 15.1 |
| (M/F) | 5/9 | 7/5 | 4/11 | 2/3 | 18/28 |
| Site (Major/Minor) | 11/2 | 10/2 | 6/8 | 1/4 | 28/16 |
| Grade (1, 2, 3) | – | 3, 0, 8 | 5, 10, 0 | – | 8, 10, 8 |
| Stage (1, 2, 3, 4) | – | 1, 3, 2, 5 | 1, 3, 4, 5 | – | 2, 6, 6, 10 |
| Size (1, 2, 3, 4) | – | 1, 5, 2, 3 | 1, 4, 3, 5 | – | 2, 9, 5, 8 |
PA, pleomorphic adenoma; MEC, mucoepidermoid carcinoma; AdCC, adenoid cystic carcinoma; NSG, normal salivary glands.
Clinic data of some cases were not available.